دورية أكاديمية
أعرض في EDS

Update on Maintenance Immunosuppression in Intestinal Transplantation.

التفاصيل البيبلوغرافية
العنوان: Update on Maintenance Immunosuppression in Intestinal Transplantation.
المؤلفون: Patwardhan S; Columbia Center for Translational Immunology, 650 West 168th Street, BB1705, New York, NY 10032, USA., Hong J; Columbia Center for Translational Immunology, 650 West 168th Street, BB1705, New York, NY 10032, USA., Weiner J; Columbia Center for Translational Immunology, 650 West 168th Street, BB1705, New York, NY 10032, USA; Division of Abdominal Organ Transplantation, Columbia University Irving Medical Center, 622 West 168th Street, PH14-105, New York, NY 10032, USA. Electronic address: jiw2106@cumc.columbia.edu.
المصدر: Gastroenterology clinics of North America [Gastroenterol Clin North Am] 2024 Sep; Vol. 53 (3), pp. 493-507. Date of Electronic Publication: 2024 Jan 23.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier Health Science Division Country of Publication: United States NLM ID: 8706257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-1942 (Electronic) Linking ISSN: 08898553 NLM ISO Abbreviation: Gastroenterol Clin North Am Subsets: MEDLINE
أسماء مطبوعة: Publication: <2005->: Philadelphia : Elsevier Health Science Division
Original Publication: Philadelphia : W.B. Saunders Co., c1987-
مواضيع طبية MeSH: Immunosuppressive Agents*/therapeutic use , Intestines*/transplantation , Intestines*/immunology , Graft Rejection*/prevention & control , Graft Rejection*/immunology , Immunosuppression Therapy*/methods, Humans ; Graft vs Host Disease/prevention & control
مستخلص: Outcomes in intestinal transplantation remain hampered by higher rates of rejection than any other solid organs. However, maintenance immunosuppression regimens have largely remained unchanged despite advances in therapies for induction and treatment of rejection and graft-versus-host disease. Recently, there have been a small number of new maintenance therapies attempted, and older agents have been used in new ways to achieve better outcomes. The authors herein review the traditional maintenance therapies and their mechanisms and then consider updates in new therapies and new ways of using old therapies for maintenance immunosuppression after intestinal transplantation.
Competing Interests: Disclosure The authors declare no commercial or financial conflicts of interest.
(Copyright © 2023 Elsevier Inc. All rights reserved.)
References: Clin Transpl. 2014;:49-54. (PMID: 26281126)
Wound Repair Regen. 2010 Jan-Feb;18(1):98-104. (PMID: 20082683)
Drug Healthc Patient Saf. 2020 Sep 08;12:151-160. (PMID: 32982466)
Am J Transplant. 2016 Oct;16(10):2973-2985. (PMID: 27037650)
N Engl J Med. 2009 Sep 3;361(10):998-1008. (PMID: 19726774)
Transplant Proc. 1998 Sep;30(6):2677-9. (PMID: 9745545)
Pediatr Transplant. 2011 Mar;15(2):128-41. (PMID: 21309962)
Transplant Proc. 2022 Sep;54(7):1944-1953. (PMID: 35933238)
Transplant Proc. 2004 Mar;36(2):309-11. (PMID: 15050141)
Semin Pediatr Surg. 2006 Aug;15(3):179-87. (PMID: 16818139)
Transpl Int. 2021 Oct;34(10):1895-1907. (PMID: 34174115)
Ann Hepatol. 2020 Sep - Oct;19(5):541-545. (PMID: 32768592)
Liver Transpl. 2001 Jun;7(6):473-84. (PMID: 11443573)
Curr Opin Immunol. 2010 Jun;22(3):333-40. (PMID: 20363604)
Ann Surg. 2009 Oct;250(4):567-81. (PMID: 19730240)
Transplant Direct. 2020 Jan 17;6(2):e527. (PMID: 32095513)
J Pediatr Surg. 2005 Jan;40(1):274-9; discussion 279-80. (PMID: 15868597)
Transplant Proc. 2012 Oct;44(8):2445-8. (PMID: 23026616)
N Engl J Med. 2005 Aug 25;353(8):770-81. (PMID: 16120857)
Transpl Immunol. 2019 Dec;57:101246. (PMID: 31526866)
Pharmacotherapy. 2022 Aug;42(8):599-633. (PMID: 36032031)
Gastroenterology. 2006 Feb;130(2 Suppl 1):S132-7. (PMID: 16473061)
N Engl J Med. 2013 Aug 22;369(8):699-710. (PMID: 23964932)
Am J Transplant. 2009 Feb;9(2):327-36. (PMID: 19120077)
Clin Transplant. 2021 Jun;35(6):e14291. (PMID: 33740822)
Lancet. 1989 Oct 28;2(8670):1000-4. (PMID: 2478846)
Am J Transplant. 2021 Feb;21 Suppl 2:316-355. (PMID: 33595193)
Ann Transplant. 2018 Feb 06;23:98-104. (PMID: 29402878)
Curr Mol Med. 2009 Sep;9(7):836-50. (PMID: 19860663)
Clin J Am Soc Nephrol. 2021 Sep;16(9):1387-1397. (PMID: 34233921)
Clin Transplant. 2021 Jul;35(7):e14324. (PMID: 34046945)
Am J Transplant. 2018 Apr;18(4):907-915. (PMID: 28925597)
Am J Transplant. 2015 Jan;15(1):210-9. (PMID: 25438622)
Transplant Proc. 2002 May;34(3):940-1. (PMID: 12034250)
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7119-24. (PMID: 19359475)
Lupus. 2005;14 Suppl 1:s2-8. (PMID: 15803924)
Am J Transplant. 2005 Jun;5(6):1430-6. (PMID: 15888051)
Transplant Proc. 2002 May;34(3):868. (PMID: 12034213)
Curr Opin Organ Transplant. 2009 Jun;14(3):250-5. (PMID: 19373085)
Transplant Direct. 2023 Aug 24;9(9):e1512. (PMID: 37636483)
N Engl J Med. 2013 Aug 22;369(8):711-21. (PMID: 23964933)
Immunol Rev. 2006 Jun;211:81-92. (PMID: 16824119)
Gastroenterology. 2014 Sep;147(3):618-627.e3. (PMID: 24859203)
Transplant Proc. 2016 Mar;48(2):473-8. (PMID: 27109981)
Paediatr Drugs. 2022 Jul;24(4):365-376. (PMID: 35604536)
J Am Soc Nephrol. 2010 Sep;21(9):1587-96. (PMID: 20634298)
Medicine (Baltimore). 2016 Apr;95(14):e3173. (PMID: 27057842)
Transplant Proc. 2002 May;34(3):936. (PMID: 12034247)
Am J Transplant. 2006;6(5 Pt 2):1111-31. (PMID: 16613591)
Clin Immunol. 2018 Aug;193:24-32. (PMID: 29842945)
Drugs. 2005;65(8):1037-50. (PMID: 15907141)
Front Immunol. 2018 Jul 31;9:1700. (PMID: 30131801)
Transpl Immunol. 2004 Sep-Oct;13(2):131-7. (PMID: 15380543)
Transplantation. 2006 Dec 15;82(11):1477-83. (PMID: 17164720)
J Surg Res. 2011 May 1;167(1):158-65. (PMID: 19922952)
Exp Clin Transplant. 2022 Jul;20(7):642-648. (PMID: 35924741)
Gut. 2019 Jan;68(1):4-5. (PMID: 30077996)
Transplantation. 2004 Jan 15;77(1):129-31. (PMID: 14724447)
Transpl Int. 2011 Dec;24(12):1216-30. (PMID: 21955006)
Transplantation. 2002 May 27;73(10):1538-42. (PMID: 12042637)
Hum Pathol. 2016 Oct;56:89-92. (PMID: 27246175)
JAMA. 1989 Mar 10;261(10):1449-57. (PMID: 2918640)
Transplantation. 1988 Feb;45(2):279-84. (PMID: 2964108)
Transplantation. 1984 May;37(5):429-33. (PMID: 6729949)
Am J Transplant. 2020 Dec;20(12):3550-3557. (PMID: 32431016)
Clin Transplant. 2018 Jul;32(7):e13290. (PMID: 29782661)
J Exp Med. 2003 May 5;197(9):1141-51. (PMID: 12732656)
Prog Transplant. 2005 Mar;15(1):60-4. (PMID: 15839373)
Am J Kidney Dis. 2000 Oct;36(4):844-50. (PMID: 11007689)
Am J Transplant. 2013 Mar;13(3):808-10. (PMID: 23331705)
Curr Opin Organ Transplant. 2022 Apr 1;27(2):119-125. (PMID: 35232925)
Curr Opin Organ Transplant. 2022 Apr 1;27(2):126-130. (PMID: 35232926)
J Pediatr Surg. 2014 Jan;49(1):13-8. (PMID: 24439573)
Gastroenterology. 2006 Feb;130(2 Suppl 1):S163-9. (PMID: 16473067)
Transplant Proc. 2022 Mar;54(2):472-475. (PMID: 35153057)
Am J Transplant. 2020 Oct;20(10):2802-2812. (PMID: 32277553)
J Gastroenterol Hepatol. 2011 Aug;26(8):1221-8. (PMID: 21595748)
N Engl J Med. 2004 Dec 23;351(26):2715-29. (PMID: 15616206)
Lancet. 2003 May 3;361(9368):1502-10. (PMID: 12737859)
Ann Surg. 2001 Sep;234(3):404-16; discussion 416-7. (PMID: 11524593)
Clin Transplant. 2019 Oct;33(10):e13684. (PMID: 31374126)
Transplant Proc. 2007 Jun;39(5):1629-31. (PMID: 17580204)
Transplantation. 2013 May 15;95(9):1160-6. (PMID: 23435456)
Drug Discov Today. 2015 Oct;20(10):1243-9. (PMID: 26050578)
Am J Transplant. 2023 Feb;23(2 Suppl 1):S264-S299. (PMID: 37132347)
معلومات مُعتمدة: K23 AI156026 United States AI NIAID NIH HHS; T32 AI148099 United States AI NIAID NIH HHS
فهرسة مساهمة: Keywords: Intestinal transplantation; Maintenance immunosuppression; Vedolizumab
المشرفين على المادة: 0 (Immunosuppressive Agents)
تواريخ الأحداث: Date Created: 20240727 Date Completed: 20240728 Latest Revision: 20240731
رمز التحديث: 20240731
مُعرف محوري في PubMed: PMC11284276
DOI: 10.1016/j.gtc.2023.12.007
PMID: 39068010
قاعدة البيانات: MEDLINE
الوصف
تدمد:1558-1942
DOI:10.1016/j.gtc.2023.12.007